Nexien BioPharma, Inc (OTC: NXEN) Developing a cannabinoid-based drug pipeline.

November 14, 2018 admin CEO Interview, Healthcare Comments Off on Nexien BioPharma, Inc (OTC: NXEN) Developing a cannabinoid-based drug pipeline.
Alex Wasyl, CEO Nexien BioPharma

 

Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential!
Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of the crowd.
Your privacy is our priority. Your email address will never be sold or shared with anyone else.

 

 

Alex Wasyl, CEO Nexien BioPharma

 

 

 

 

 

 

Nexien BioPharma, Inc (OTC: NXEN) CEO Interview with Alex Wasyl discussing the company’s cannabinoid-based drug development pipeline. Drug development targets include, epliepsy, myotonia and other markets.




Related Articles

CEO Interview

Elixinol Global Limited (ASX: EXL) (OTC: ELLXF) Emerging leader in CBD and Hemp foods and consumer products

December 11, 2018 admin CEO Interview, Consumer, Spotlight Stocks Comments Off on Elixinol Global Limited (ASX: EXL) (OTC: ELLXF) Emerging leader in CBD and Hemp foods and consumer products

  Get our FREE Newsletter! Discover Stocks with +1,000% Upside Potential! Thank you for subscribing. Something went wrong. Join over 100,000 investors and business leaders worldwide. Discover the Next Super Stock before the rest of […]

Consumer

American Premium Water Corp. (OTC: HIPH) Announces Sponsorship of NFL Draft Party Hosted by Star New York Jets Running Back Le’Veon Bell

April 30, 2019 admin Consumer, Newsmakers Comments Off on American Premium Water Corp. (OTC: HIPH) Announces Sponsorship of NFL Draft Party Hosted by Star New York Jets Running Back Le’Veon Bell

The event further establishes LALPINA CBD’s connection to professional athletes as the Company looks to penetrate the $30 billion US fitness market PLAYA VISTA, Apr 25, 2019  – American Premium Water Corporation(OTC: HIPH) announces that […]

Consumer

Medicine Man Technologies (OTC: MDCL) Cannabis operator on track for $40 mil revenues (and profits) with new acquisitions

February 1, 2019 admin Consumer Comments Off on Medicine Man Technologies (OTC: MDCL) Cannabis operator on track for $40 mil revenues (and profits) with new acquisitions

[embedyt] https://www.youtube.com/watch?v=ZL8tb5EFlWQ[/embedyt] Medicine Man Technologies (OTC: MDCL) CEO Interview with Andy Williams, co-founder, and CEO. In this update to our December 2018 interview, Andy provides an update on the company’s progress into a vertically integrated […]